Contact
searchSearch
HMP Global

Embolization Topic Center

Features

Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management
Interview
Minimally Invasive Treatment Options for Osteoarthritis-Related Knee Pain: Where Are We Now?
06/10/2025
Yan Epelboym, MD, MPH
Yan Epelboym, MD, MPH, discusses embolization and ablation for OA-related knee pain and why they are good options to consider for patients who have not responded to other nonsurgical treatments.
Yan Epelboym, MD, MPH, discusses embolization and ablation for OA-related knee pain and why they are good options to consider for patients who have not responded to other nonsurgical treatments.
Yan Epelboym, MD, MPH, discusses...
06/10/2025
Vascular Disease Management
OBL Corner
Performing Embolization in the Office-Based Lab
05/16/2025
Christoph A. Binkert, MD, FSIR
Interventional radiologist Christoph A. Binkert, MD, FSIR, discusses why the OBL is a good setting for embolization and the role of interventional radiology in the procedure.
Interventional radiologist Christoph A. Binkert, MD, FSIR, discusses why the OBL is a good setting for embolization and the role of interventional radiology in the procedure.
Interventional radiologist...
05/16/2025
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Embolotherapy
Instylla Announces FDA Clearance of Tembo™ Embolic System
01/29/2025
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held...
01/29/2025
Vascular Disease Management

Videos

Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr. Maureen Kohi
ISET 2024
What's New in Uterine Artery Embolization for Fibroids and Adenomyosis; Patient Selection and Technique for Hemorrhoid Embolization
02/15/2024
Maureen Kohi, MD, FSIR, FAHA
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi...
02/15/2024
Vascular Disease Management
Gloria Salazar, MD, FSIR
ISET 2023
Treating Uterine AVMs, Hemorrhoids, Venous Ulcers, and Dealing With Complications
02/14/2023
Gloria Salazar, MD, FSIR
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR,...
02/14/2023
Vascular Disease Management
SIR 2022
Dr. Gloria Salazar at SIR 2022
06/15/2022
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke...
06/15/2022
Vascular Disease Management
Gloria Salazar, MD, FSIR
Video
Pelvic Venous Disease: New Nomenclature and Implications on Therapy
02/23/2022
Gloria Salazar, MD, FSIR
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022,...
02/23/2022
Vascular Disease Management
Videos
Uterine Fibroid Embolization: A Bellweather for the Rapidly Expanding Field of “Embolic Therapy”
04/21/2021
04/21/2021
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
McCall Walker, MD
Video Commentary
The Persistent Challenge of Peripheral Arterial Calcium
12/22/2025
McCall Walker, MD
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker, MD, discusses the article by Finn et al, "Dealing With Dense Calcium".
In this video, McCall Walker,...
12/22/2025
Vascular Disease Management
Dr Nagarsheth
Sponsored Video
“Artix handles the complexity we see in real arterial cases.”
12/01/2025
Khanjan Nagarsheth, MD, MBA, RPVI
Dr KJ Nagarsheth, Professor of Surgery, Division of Vascular Surgery, at the University of Maryland School of Medicine, offers a concise, real-world readout on the clinical and procedural value of the Artix thrombectomy system.
Dr KJ Nagarsheth, Professor of Surgery, Division of Vascular Surgery, at the University of Maryland School of Medicine, offers a concise, real-world readout on the clinical and procedural value of the Artix thrombectomy system.
Dr KJ Nagarsheth, Professor of...
12/01/2025
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
Video Commentary
Chronic Limb-Threatening Ischemia: Changing the Present Algorithm of Evaluation and Therapy
11/20/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
In this video, Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
In this video, Dr Walker...
11/20/2025
Vascular Disease Management
Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest
Dr Desai
Sponsored Video
Nimesh Desai, MD, Shares His Perspective on Recently Published 5-Year Outcomes in Acute Complicated Type B Aortic Dissection
11/01/2025
Nimesh Desai, MD, PhD
Dr Desai shares his perspective on the key long-term outcomes of the US IDE Clinical Trial, Type B Dissection.
Dr Desai shares his perspective on the key long-term outcomes of the US IDE Clinical Trial, Type B Dissection.
Dr Desai shares his perspective...
11/01/2025
Vascular Disease Management
Reflow AMP Video
Sponsored Video
Transforming BTK CLTI Treatment With Spur RST: Leading Experts Explore Breakthrough Technology, Clinical Performance, and Real-World Application
10/27/2025
Join a distinguished panel of vascular experts as they discuss the evolving landscape of endovascular therapy for BTK CLTI.
Join a distinguished panel of vascular experts as they discuss the evolving landscape of endovascular therapy for BTK CLTI.
Join a distinguished panel of...
10/27/2025
Vascular Disease Management
Video
Venous Thromboembolism: A Cost Analysis
10/15/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor Craig Walker, MD, comments on Mary Yost’s article, “The Cost of Venous Thromboembolism”.
In this video, Clinical Editor...
10/15/2025
Vascular Disease Management
Dr Nakama
AMP 2025
One-Year Outcomes of Drug-Eluting Stent vs Drug-Coated Balloon for Femoropopliteal Artery Lesions: The BEASTARS Study Results
10/08/2025
Tatsuya Nakama, MD
In this video recorded at AMP 2025, Tatsuya Nakama, MD, discusses his AMP presentation on 1-year results from the BEASTARS study.
In this video recorded at AMP 2025, Tatsuya Nakama, MD, discusses his AMP presentation on 1-year results from the BEASTARS study.
In this video recorded at AMP...
10/08/2025
Vascular Disease Management

Presentations

Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Teri Yates
AMP 2025
The Pros and Cons of OBLs and ASCs
08/15/2025
Teri Yates
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable Physician Advisors and DocCentric Surgery Centers, delivered an in-depth presentation that provided a detailed comparison between OBLs and ASCs. She highlighted regulatory distinctions, facility requirements,...
Teri Yates, CEO of Accountable...
08/15/2025
Vascular Disease Management
Earl Johnson MD
AMP 2025
Plastic Surgery: Enhancing Outcomes Through Early Involvement
08/15/2025
Earl M. Johnson, Jr., MD, FACS
Earl M. Johnson, Jr., MD, FACS, presented a discussion on the transformative role plastic surgery can play when incorporated early in a patient’s treatment plan. He emphasized that proactive, coordinated intervention significantly enhances...
Earl M. Johnson, Jr., MD, FACS, presented a discussion on the transformative role plastic surgery can play when incorporated early in a patient’s treatment plan. He emphasized that proactive, coordinated intervention significantly enhances...
Earl M. Johnson, Jr., MD, FACS,...
08/15/2025
Vascular Disease Management
Caroline Fife, MD
AMP 2025
Estimating the Problem of Chronic Wounds
08/15/2025
Caroline E. Fife, MD, FAAFP, CWS, FUHM
Caroline E. Fife, MD, underscored how gaps in diagnosis coding, classification disagreements, and underreporting distort both prevalence and cost estimates, leading to inadequate attention and funding.
Caroline E. Fife, MD, underscored how gaps in diagnosis coding, classification disagreements, and underreporting distort both prevalence and cost estimates, leading to inadequate attention and funding.
Caroline E. Fife, MD,...
08/15/2025
Vascular Disease Management
Abigail Mize
AMP 2025
The Role of Ultrasound in Identifying and Treating Complications
08/15/2025
Abigail Mize, BS, RDCS, RVT
Abigail Mize, BS, RDCS, RVT, gave a presentation entitled "Utilization of Ultrasound to Identify and Treat Complications." She emphasized that while prevention remains the best strategy, complications can arise even with the most skilled...
Abigail Mize, BS, RDCS, RVT, gave a presentation entitled "Utilization of Ultrasound to Identify and Treat Complications." She emphasized that while prevention remains the best strategy, complications can arise even with the most skilled...
Abigail Mize, BS, RDCS, RVT,...
08/15/2025
Vascular Disease Management
Dr Brodmann
AMP 2025
Transradial Access Shifts the Paradigm in Treating Chronic Limb-Threatening Ischemia
08/14/2025
Marianne Brodmann, MD
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered a detailed update on how she employs radial artery access to manage chronic limb-threatening ischemia.
Marianne Brodmann, MD, delivered...
08/14/2025
Vascular Disease Management
Dr Pliagas
AMP 2025
How IVUS Changed My Intervention
08/14/2025
George Pliagas, MD, FACS, FRCSC
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and Imaging in CLTI” session, George Pliagas, MD, FACS, FRCSC, shared how IVUS has reshaped his approach to treating peripheral vascular disease.
During Thursday’s “Diagnosis and...
08/14/2025
Vascular Disease Management
Dr Foster
AMP 2025
Novel Radiation Shielding Device Shows Dramatic Drops in Operator Radiation in an OBL Setting
08/14/2025
Robert Foster, MD
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a study that addresses how to protect clinicians from scatter radiation without the toll of heavy lead garments.
Robert Foster, MD, discusses a...
08/14/2025
Vascular Disease Management
Dr Roy
AMP 2025
Cross-Sectional Imaging is Reshaping CLTI Care
08/14/2025
Trisha Roy, MD, PhD, FACS
Trisha Roy, MD, PhD, FACS, outlines why modern cross-sectional imaging performed before peripheral vascular intervention can be the difference between limb salvage and treatment failure in patients with CLTI.
Trisha Roy, MD, PhD, FACS, outlines why modern cross-sectional imaging performed before peripheral vascular intervention can be the difference between limb salvage and treatment failure in patients with CLTI.
Trisha Roy, MD, PhD, FACS,...
08/14/2025
Vascular Disease Management
Dr Tokuda
AMP 2025
Atherectomy + DCB vs Stent-Based Repair for Severely Calcified Femoropopliteal Disease
08/13/2025
Takahiro Tokuda, MD
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro...
08/13/2025
Vascular Disease Management
Dr Zeller
AMP 2025
WOUNDSinCLTI Trial Update: Pathogen-Driven Insights Into Limb Salvage in CLTI
08/13/2025
Thomas Zeller, MD, PhD
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the Universitaets-Herzzentrum Freiburg, Bad Krozingen, Germany, presented the inaugural findings from the WOUND infection and clinical outcomeS IN patients with Chronic Limb-Threatening Ischemia (WOUNDSinCLTI) study,
Thomas Zeller, MD, from the...
08/13/2025
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Embolotherapy
Instylla Announces FDA Clearance of Tembo™ Embolic System
01/29/2025
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held...
01/29/2025
Vascular Disease Management
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
11/30/2023
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November...
11/30/2023
Vascular Disease Management
News
Embolization: Dr. Gloria Salazar Named New Section Editor of Vascular Disease Management
10/26/2021
VDM welcomes new Section Editor.
VDM welcomes new Section Editor.
VDM welcomes new Section Editor.
10/26/2021
Vascular Disease Management
Acquisitions
Boston Scientific Announces Agreement to Acquire Penumbra, Inc.
01/15/2026
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA,...
01/15/2026
Cath Lab Digest
Peripheral Arterial Disease
CIS and Terrebonne General Are First in Louisiana to Use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter
01/09/2026
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA...
01/09/2026
Vascular Disease Management
Radiation Safety
Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection
01/08/2026
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind,...
01/08/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management
Neuro Intervention
Penumbra Receives CE Mark for MIDWAY and ACCESS25 Delivery Catheters in Europe
12/19/2025
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery...
12/19/2025
Vascular Disease Management
Thrombectomy
Study Finds CAVT (Computer-Assisted Vacuum Thrombectomy) Shortens Hospital Stay and May Ease Burden on Hospital Systems
12/16/2025
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT,...
12/16/2025
Cath Lab Digest
Intravascular Imaging
Philips Agrees to Acquire SpectraWAVE Inc., Advancing Next-Generation Coronary Intravascular Imaging and Physiological Assessment With AI
12/16/2025
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s...
12/16/2025
Vascular Disease Management
Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management
Meeting Update
Multidisciplinary approaches to stroke prevention, cardiac and carotid imaging, advanced ablation strategies, risk reduction and long-term follow up at Western AFib 2026
12/12/2025
Nassir F. Marrouche, MD
Atrial fibrillation is rising at an alarming pace, and its clinical impact continues to deepen. Atrial fibrillation continues to expand in scale and complexity, with the Centers for Disease Control and Prevention estimating that 12.1...
Atrial fibrillation is rising at an alarming pace, and its clinical impact continues to deepen. Atrial fibrillation continues to expand in scale and complexity, with the Centers for Disease Control and Prevention estimating that 12.1...
Atrial fibrillation is rising at...
12/12/2025
EP Lab Digest
Radiation Exposure
Dr. Patrick Muck Presents Lead-Free EVAR Experience Using Rampart Guardian at VEITHsymposium 2025
12/09/2025
New York, New York -- November 2025 -- Patrick E. Muck, MD, RVT, of TriHealth-Good Samaritan Hospital in Cincinnati, Ohio, presented new findings at the 2025 VEITHsymposium demonstrating that endovascular aortic repair (EVAR) can be...
New York, New York -- November 2025 -- Patrick E. Muck, MD, RVT, of TriHealth-Good Samaritan Hospital in Cincinnati, Ohio, presented new findings at the 2025 VEITHsymposium demonstrating that endovascular aortic repair (EVAR) can be...
New York, New York -- November...
12/09/2025
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use